ABSTRACT Background: For many people, maintenance of weight loss is elusive. Whereas high-protein (HP) diets have been found to be superior to high-carbohydrate (HC) diets for weight loss in the short term, their benefits long term are unclear, particularly for weight maintenance. Furthermore, the literature lacks consensus on the long-term effects of an HP diet on cardiovascular disease risk factors. Objective: The objective was to investigate whether macronutrient dietary composition plays a role in weight maintenance and in improvement of cardiovascular disease risk factors. Design: The study comprised 2 phases. Phase 1 featured a verylow-energy diet for 3 mo. In phase 2, the subjects were randomly assigned to an HP or an HC diet for 12 mo. The diets were isocaloric, tightly controlled, and individually prescribed for weight maintenance. The subjects were overweight or obese but otherwise healthy men and women. Results: The subjects lost an average of 16.5 kg during phase 1 and maintained a mean (6SEM) weight loss of 14.5 6 1.2 kg (P , 0.001) during phase 2; no significant differences between groups were observed. By the end of the study, reductions in systolic blood pressure were 14.3 6 2.4 mm Hg for the HP group and 7.7 6 2.2 mm Hg for the HC group (P , 0.045). Forty-seven percent of the 180 subjects who began the study completed both phases.
INTRODUCTION
In recent years there has been renewed interest in high-protein diets for weight loss. An increase in the protein content of the diet is usually accompanied by a reduction in carbohydrate content; thus, the terms "high protein" and "low carbohydrate" are used interchangeably in the literature; despite the protein content of dietary treatment ranging from 25% (1) to 45% (2) . Many studies with a duration of up to 6 mo have found that diets high in protein achieve greater weight loss than do high-carbohydrate diets (2) (3) (4) .
Very-low-energy diets (VLEDs) have been used effectively for at least the past 20 y to achieve large and rapid weight losses. Whereas one analysis of the literature found that long-term weight regain experienced by individuals who followed a VLED is no worse than weight regain experienced by individuals who followed low-energy diets (5), another review found that individuals who followed VLEDs maintained a significantly greater weight losses than did subjects who followed a low-energy balanced diet (6) . The type of diet and intensity and duration of follow-up are likely to have an effect on the long-term success of weight maintenance.
Little research has been done on the role of a high-protein (HP) diet on the maintenance of weight loss. Lejeune et al (7) showed that, in overweight and obese subjects who followed a VLED for 4 wk (mean weight loss: 6.3 6 2.0 kg), a higher-protein, weightmaintenance diet resulted in significantly less weight regain over the subsequent 6 mo (0.8 compared with 3.0 kg; P , 0.05)). The higher-protein diet consisted of 18% protein and was compared with a 15% protein control diet. The higher-protein group consumed the additional protein in the form of protein supplements, whereas the control group consumed their usual diet without additional supplements. Weight maintenance after weight loss was also investigated by Claessens et al (8) . In their study, overweight and obese subjects underwent weight loss by following a VLED for 5 to 6 wk. The subjects were then randomly assigned to an HP or high-carbohydrate (HC) weightmaintenance diet for 12 wk. Subjects in the HP diet group consumed 25% of their energy intake as protein and protein supplements twice daily. The HC group consumed 55% of their energy as carbohydrate, along with twice daily maltodextrin supplements. The HP group maintained greater weight loss than did the HC group.
The purpose of our study was to achieve a large and rapid weight loss using a VLED and to then investigate the effects of 12 mo of weight maintenance with a low-fat, HP diet or a low-fat, HC diet on body weight in overweight and obese men and women. The subjects were free-living and were not provided with any food or supplements during the weight-maintenance period.
SUBJECTS AND METHODS
The study was approved by the Human Research Ethics Committees of the Royal Melbourne and Austin Hospitals. The subjects were recruited by newspaper advertisement and word of mouth. They were men and women aged 18 to 75 y whose body mass indexes (BMI; in kg/m 2 ) were 30 or 27 and had comorbidities. In providing their informed consent to participate, the subjects indicated their willingness to be randomly assigned to study groups and to adhere to the study protocol. Individuals with a history or presence of significant disease, endocrine disorder, psychiatric illness, and alcohol or drug abuse were excluded. In addition, women were excluded if they were lactating, pregnant, or planned to become pregnant during the study.
Study design
The study had a parallel, randomized design that consisted of 2 time phases. Phase 1 was a 3-mo intensive weight-loss phase that all subjects began at the start of the study. Phase 2 refers to the 12-mo weight-maintenance phase during which eligible subjects were placed on either an HC or an HP diet after the completion of phase 1. Phase 1+2 refers to the entire study duration, ie, both phase 1 and phase 2.
Dietary instructions
During phase 1, the subjects were provided with the commercially available VLED, (Optifast; Nestle Nutrition, Frankfurt, Germany). As per the manufacturer's recommendations, the VLED was consumed 3 times/d as a meal replacement for a 12-wk period and was taken as a milkshake, soup, or dessert. The subjects were also permitted to consume up to 2 cups of low starch vegetables daily with a small amount of oil (5 mL) and a minimum of 2 L water or low-energy drinks. This provided subjects with '500-550 kcal/d. The subjects attended the clinic individually each fortnight to be weighed, counseled on the use of the VLED, and be provided with a 2-wk supply of the VLED. The subjects were required to lose 10% of their body weight during phase 1 to progress to the weight-maintenance phase (phase 2). In phase 2, the subjects were randomly assigned to the HC or HP dietary group (see Statistics). Harris-Benedict equations were used to estimate individual basal metabolic rate (BMR) (9) . Each individual subject's total energy expenditure was calculated as BMR multiplied by an activity factor of 1.3, which was considered appropriate for weight maintenance in mildly active adults. The subjects were counseled to consume an energy intake consistent with weight maintenance, and this information was reinforced at each of the monthly visits attended by subjects during phase 2, particularly if subjects began to regain weight. The subjects received meal plans and recipes appropriate to the dietary group to which they had been allocated. They bought and prepared their own food and were invited to attend group cooking classes that were specific to the HP or HC dietary treatments.
Subjects in the HP group were instructed to consume 30% of their intake as protein, whereas subjects in the HC group were instructed to consume 15% of their intake as protein. Both dietary groups were recommended to consume lean red meat 3-4 times/wk to meet the recommended intakes of iron and zinc in line with Australian Dietary Guidelines. Both groups were advised to reduce their fat intake to ,30% of their intake, with a particular emphasis on reducing saturated fat. Carbohydrates with a low glycemic index (GI) were recommended to both groups. Issues such as comfort eating, snacking, reading food labels, and healthy carryout and eating-out options were addressed during monthly counseling sessions. The subjects were also encouraged to practice healthy behaviors such as aerobic exercise 3 times/wk.
Data collection
The screening visit included a medical history, physical examination, and blood test. Body weight was measured at each visit at approximately the same time of day by using the same digital calibrated scales. The subjects wore street clothing, removed their shoes, and voided their bladder before being weighed. At each visit, bioelectrical impedance analysis was used to measure body composition (Tanita TBF-300; WW Wedderburn Pty, Ltd, Sydney, Australia) by using the standard adult mode of measurement. At each visit, waist and hip circumferences were measured to the nearest 0.5 cm, and the mean of 2 readings taken with a spring-loaded tape measure was recorded. Waist circumference was measured at the level of the umbilicus and hip circumference at the level of the greater trochanters. Dietary compliance was estimated by using 3-d food diaries. The subjects were instructed by a dietitian to provide as much information on food and drinks consumed (eg, brand name, volume, weight, and ingredients) over 3 consecutive days (2 weekdays and 1 weekend day). The food diaries and instructions for their use were provided at months 8 and 14 of the study. The subjects were asked to complete the diaries immediately before their scheduled visits at months 9 and 15. The diaries provided data on energy intake midway through and at the end of phase 2-the weight-maintenance phase. Food diaries were analyzed by using Foodworks Professional Edition version 3.02.581 (Xyris Software, Highgate Hill, Australia). Twenty-four-hour urine samples were collected to coincide with food diary collection midway through (month 9) and at the end of phase 2 (month 15). The subjects were thoroughly educated on the procedure for collecting an accurate 24-h urine sample and were also provided with written instructions. The subjects were instructed to collect all urine excreted after the first volume voided in the morning until and including the first morning urine voided the following day. Blood samples were collected via venipuncture after an overnight fast. The analyses were performed by the Pathology Department at the Royal Melbourne Hospital.
Statistics
The subjects were randomly assigned to the HP or HC group by using randomly chosen block sizes of 2, 4, and 6 within 8 strata that accounted for sex, BMI (,35 or 35), and age (,40 or 40 y). After successfully completing phase 1, eligible subjects were allocated to the next available treatment in the computergenerated randomized list of treatments for their corresponding strata.
All P values were 2-sided, and a P value 0.05 was considered to indicate statistical significance. Values are provided as mean 6 SEM unless otherwise indicated. The analysis was performed by using Minitab statistical software (version 14.0; Minitab, Inc, State College, PA).
The statistical analysis of study completion measurements consisted of 2 distinct analyses. The first was a primary intention to treat (ITT) analysis that consisted of 2 different approaches to missing data. The first approach used was the last observation carried forward (LOCF). The second approach was return to baseline (RTB) for study dropouts. The second analysis considered study completers only (CO). For each measurement analysis, 2 general linear models (GLMs) were fit: the first dealing with measurement changes over phase 1+2 from baseline and the second dealing with measurement changes during phase 2. Each GLM had treatment group (HC or HP), sex (male or female), and the interaction between treatment and sex as fixed effects.
The response variable for the first GLM (phase 1+2) was the change in the measurement of interest at study completion compared with baseline and included the measurement at baseline, baseline weight, and age as covariates. The response variable for the second GLM (phase 2) was the change in the measurement of interest at study completion compared with the measurement at completion of phase 1. Change of measurement at completion of phase 1 compared with baseline and age were included as covariates. To assess the strength of linear relations between paired data, we used Pearson correlation coefficients. The associated P value is reported to test for nonzero correlation.
RESULTS

Baseline characteristics
The subjects were well matched according to baseline characteristics ( Table 1 ). There were no significant differences in baseline demographic, anthropometric, or metabolic variables between the subjects who went on to be randomly assigned to either of the 2 dietary groups in phase 2.
Attrition
As can be seen in Figure 1 , 180 persons were screened to take part in the study. One man was excluded at the screening stage because of a diagnosis of hemochromatosis. Of the 179 subjects that began phase 1 of the study, 20 voluntarily withdrew because of intolerance to the meal replacement. Fourteen subjects did not succeed in losing the required 10% of their body weight. Four of these 14 subjects were not included in the analysis because they had not adequately complied with the study protocol because they attended less than one-half of the required visits during phase 1. Four subjects who successfully completed phase 1 decided not to continue in the study. One hundred and forty-one (70 men and 71 women) subjects (78% of the initial number recruited) completed phase 1 and progressed to phase 2, in which they were randomly assigned to either an HP or HC diet. There were 35 men in both the HC and HP diet groups and 35 women in the HC group and 36 in the HP group.
After randomization, approximately equal numbers of subjects withdrew from each dietary treatment group. Three subjects who withdrew from the HP group were not included in the analysis because they did not attend a sufficient number of scheduled appointments to be considered compliant with the protocol. One subject withdrew from the study after randomization and before commencing any of the phase 2 procedures. No subject withdrew because of symptomatic adverse effects of the diet. Forty-two subjects completed the HP diet, and 42 subjects completed the HC diet, which indicated that 59.6% of the 141 subjects who commenced phase 2 completed this phase. Except for age and blood pressure measurements, there were no significant differences in baseline characteristics between the subjects who completed the study and those who dropped out. On average, the subjects who completed the study were older (46.4 6 1.1 y) than those who dropped out (40.0 6 1.0 y) (P , 0.001). Compared with the subjects who dropped out, the subjects who completed the study also had, on average, a higher baseline systolic blood pressure (136.3 6 1.8 mm Hg compared with 129.1 6 1.6 mm Hg; P = 0.004) and a higher baseline diastolic blood pressure (85.3 6 1.2 mm Hg compared with 82.0 6 1.0 mm Hg; P = 0.032).
Anthropometric data
At the completion of phase 1, the mean weight loss experienced by all subjects was 16.5 6 0.5 kg (P , 0.001), as seen in Table 2 . This equated to a mean weight loss of 14.7% (99% CI: 215.47, 213.92; P , 0.001). All anthropometric measurements decreased significantly during phase 1 for all subjects. The subjects who completed both phases of the trial experienced a small but significant increase in weight and BMI during phase 2 (weight: 3.6 6 0.9kg, P , 0.001; BMI: 1.2 60.3, P , 0.001), as evident in Table 3 . However, weight at completion of the study was on average 14.5 6 1.2 kg (P , 0.001) less than the baseline weight for all completing subjects, which equates to a decrease of 12.98% (99% CI: 214.96, 211.00) in body weight ( Table 4) . There was no difference between the HP and HC groups in weight or BMI changes during phase 1 or phase 2: 15% of the HC group compared with 26% of the HP group lost additional weight during phase 2 (P = 0.205). During phase 2, 42.5% of the HC group and 47.6% of the HP group regained ,20% of the initial weight lost during phase 1. Whereas all subjects experienced a significant decrease in both fat mass and fat-free mass during phase 1, all subjects experienced a significant increase in fat mass and no significant change in fat-free mass in phase 2. When the results for phase 1 and 2 are taken together, from the beginning to the end of the study, all subjects experienced significant decreases in weight, fat mass, and fat-free mass, with no difference observed between the groups. Significant reductions in waist and hip circumferences were achieved during phase 1, with no further changes in these measurements during phase 2. The reductions, however, were maintained until the end of the study by those completing the study (Table 4) .
The ITT analysis of those who withdrew from the study (Table  4) , in which baseline weights (RTB) or the last recorded (LOCF) weight were carried forward and analyzed, still showed that there was no difference in weight loss between the HP and HC dietary groups after 12 mo of dietary counseling.
Lipids
As is evident in Table 1 , mean lipid concentrations were in the normal range at baseline for all subjects. For all subjects who completed phase 1, total cholesterol and triglycerides decreased significantly after the VLED (Table 2 ). At the end of the study, total and LDL-cholesterol and triglyceride concentrations in those subjects who had gone on to complete phase 2 (CO) remained significantly reduced compared with baseline concentrations (Table 4) . Although the changes in LDL during both phases I and II were not significant, LDL cholesterol decreased significantly from baseline by the end of phase 2 (Table 4) . There was no change in HDL during phase 1 (Table 2) ; however, during the 12 mo of the dietary treatment in phase 2, a significant increase in mean HDL (P , 0.001) was observed (Table 3) and was sustained until the end of the study by the completing subjects (Table 4) . There was no difference in lipid concentrations between the 2 dietary groups at baseline or at the end of phase 1 or phase 2. The significant changes in total, LDL, and HDL cholesterol and in triglycerides experienced by the subjects who completed phases I and II were not observed in the ITT analyses (Table 4 ).
Blood pressure
Blood pressure measured in the 2 dietary groups was within the normal range at the commencement of the study (Table 1) and remained so for the duration of the study. Pairwise comparisons across all subjects showed a significant mean decrease in SBP of 13.2 6 1.4 mm Hg (P , 0.001) from baseline to the end of phase 1 (Table 2) . After the subjects were randomly assigned to the treatment groups at month 3, no significant difference in mean SBP decrease from baseline was detected between the 2 groups (CO) at this time (P = 0.375). The mean decrease in SBP during phase 1 was 12.3 6 2.1 mm Hg for the HC group and 14.9 6 2.1 mm Hg for the HP group (Table 2) .
Although subjects in both treatment groups experienced a significant increase in SBP during phase 2 (4.7 6 1.9 mm Hg, P , 0.014; Table 3 ), all subjects who completed the study experienced an overall decrease in SBP from baseline of 11.1 6 1.7 mm Hg (P , 0.001) ( Table 4 ). For those subjects who completed the study (CO), the mean decrease in SBP from baseline to the end of the study was 14.3 6 2.4 mm Hg for the HP group and 7.7 6 2.2 mm Hg for the HC group (Table 4) , and the difference between the 2 groups was statistically significant (P , 0.045). When this finding was investigated further by using a GLM, the dietary treatment (HP) was found to be a significant fixed effect in influencing SBP in subjects who completed the study and in the ITT analyses ( Table 5 ). The estimated model coefficient for treatment indicated that a larger decreases in SBP can be expected with an HP diet after weight loss. The subjects' baseline SBP and FIGURE 1. Status of subjects throughout the trial. 1 Subjects with a diagnosis of hemochromatosis that precluded participation. 2 Poor compliance with protocol; did not attend a sufficient number of study visits. 3 Decided not to continue in study after randomization.
baseline weight, along with age, were found to be significant covariates.
Further statistical analyses were then conducted to investigate the effect of the dietary treatments on SBP during phase 2. A GLM was used that considered sex, treatment, sex · treatment interaction, age, and a reduction in SBP during phase 1 ( Table  6 ). It was found that the dietary treatment was a significant fixed effect in the CO and LOCF analyses and was nearly significant in the RTB analysis; the estimated model coefficient indicated larger expected increases in SBP for the HC diet. The SBP reduction at month 3 was a significant covariate in the CO and ITT analyses.
A significant mean decrease in DBP of 8.5 6 1.1 mm Hg (P , 0.001) was detected across all subjects at the end of month 3 (Table 2) , with no significant difference between treatment group reductions in DBP after randomization (P = 0.283). As was observed for SBP, all CO subjects experienced a further small but significant increase in DBP during phase 2 (3.7 6 1.4 mm Hg, P , 0.012; Table 3 ), but there was no difference in the increase between the 2 dietary groups. Again a GLM was used that considered sex, treatment, sex · treatment interaction, age, and a reduction in DBP during phase 1. Only the reduction in DBP reduction at month 3 was a significant covariate for predicting reduction in DBP during phase 2 for the CO and in the ITT analysis (Table 6) .
At the study's completion, the mean decrease in DBP from baseline for the CO was 7.8 6 1.8 mm Hg for the HP group and 2.4 6 1.7 mm Hg for the HC group (P , 0.034) (Table 4) . However, pairwise comparisons to account for individual subjects showed that both groups experienced comparable mean increases in DBP of '3.7 mm Hg from month 3 to study completion (Table 3) . A GLM using dietary treatment as a fixed effect did not show it to be significant. The covariate baseline DBP was significant for the CO and in the ITT, whereas weight was a significant covariate for the CO (Table 5) .
Dietary compliance
Compliance with the dietary recommendations was assessed with food diaries and by the objective measures of urea excretion and weight maintenance. Food diaries in conjunction with 24-h urine collections were satisfactorily completed by 6 men and 5 women in the HP group at month 9 and by 10 men and 6 women in the HP group at month 15. In the HC group, complete food diaries and 24-h urine collections were adequately completed by 5 men and 5 women at month 9 and by 9 men and 4 women at month 15. There was no difference in weight regain between those subjects who did and did not supply food diaries in conjunction with urine collections; the subjects who did comply regained 2.9 6 0.7 kg and those who did not comply regained 3.1 6 0.5 kg by the end of the study (P = 0.375) Estimated energy requirements for weight maintenance were calculated for the mean body weight of the men and women. When these estimates were compared with the energy intakes calculated from the subjects' food records, it was apparent that, on average, women in both study groups had underestimated their food intake and thus their energy intakes (mean calculated intake = 2044 kcal; mean reported intake = 1370 kcal; P , 0.001). The men, however, did not show such disparity in their reported and calculated energy intakes (mean calculated intake = 1771 kcal; mean reported intake = 1765 kcal; P = 0.961). Measurement changes from the end of phase 1 to the end of phase 2 for all individuals who completed phase 1 or who were randomly assigned to the high-carbohydrate (HC) or high-protein (HP) group 
TABLE 4
Measurement changes from baseline to the end of phase 2 for all individuals who completed phases 1 and 2 or who were randomly assigned to the high-carbohydrate (HC) or high-protein (HP) group at the end of phase 1 
HIGH-PROTEIN DIET AND WEIGHT MAINTENANCE
Actual protein intake was calculated from urinary urea measured in 24-h urine volume by using the following formulas (10):
Urinary urea ðin mg=dLÞ ¼ urinary urea 3 24 2 h urine volume=100 ð1Þ
Nonurea nitrogen ðmg=dÞ ¼ weight of the subject ðkgÞ 3 31 ð3Þ
The subjects were assumed to be in nitrogen balance and from this we could calculate nitrogen and thus protein intake. From measured urinary urea, the average protein intake at month 9 (half way through phase 2) was calculated to be 95.9 g/d for the HC group and 120.8 g/d for the HP group ( Table 7) . At month 15 (end of phase 2), the mean protein intakes for the HC and HP groups had increased significantly from month 9 to 110.2 and 136.1 g/d respectively (P , 0.006).
The mean (6SD) total urine collected was 2370 6 808 mL for the whole study population, with volumes ranging from 1092 to 3959 mL for the 3 time points at which it was measured. This is in line with expected urine output over 24 h. There were no significant differences in urine volume between the HP and HC groups at any time point. The correlation between protein intake estimated from food diaries and calculated from urine urea output was investigated by using Pearson's correlation coefficients. A significant positive correlation of 0.329 (P = 0.036) was seen at month 9 and 0.353 (P = 0.010) at month 15. A paired-sample t test showed no difference in protein intake estimated by food diaries or calculated by urinary urea for the HC group at month 9 (Table 7) . However, the protein intake calculated from urine urea was significantly higher than the estimated intake from food diaries for HC group at month 15 and for the HP group at months 9 and 15. Two-sample t tests showed no significant difference in protein intake between the HC and HP groups estimated from food diaries at month 9, but there were significant differences between the protein intakes estimated from food diaries at month 15 and calculated from urinary urea between the 2 groups at months 9 and 15 ( Table 7) . The food diaries of the HC group indicated that the group consumed, on average, significantly greater than the recommended 15% of their energy from protein at both months 9 and 15 and significantly less than the recommended 55% of their energy from carbohydrate ( Figure 2) . The mean macronutrient consumption of the HP group reported in food diaries was not significantly different from the recommended intakes. Because of the small sample sizes, the P values reported for this analysis were obtained by using Wilcoxon's signed rank test. Both the HP and HC groups consumed minimal amounts of alcohol (,3% of energy intake), and there were no significant differences between the 2 groups in their consumption at either time point.
The mean fiber intake reported in the food diaries was 21.7 g/d, with no significant difference between the 2 groups or over the 2 2 Approximately one-third of the participants who provided food diaries and 24-h urine samples at month 9 also provided them at month 15.
3 Mean 6 SEM (all such values). 4 Independent sample t test (intergroup comparison).
FIGURE 2.
Recommended compared with reported macronutrient intakes in the high-protein (HP) and high-carbohydrate (HC) diet groups at months 9 and 15. Month 9 represents the half-way point of phase 2, and month 15 represents the end of phase 2. HP group: n = 11 at month 9, and n = 16 at month 15; HC group: n = 10 at month 9, and n = 13 at month 15. The dashed lines represent recommended intakes (HC diet: 15% protein, 55% carbohydrate, and 30% fat; HP: 30% protein, 40% carbohydrate, and 30% fat). The bold lines represent the median data for the group, and P values represent the differences between reported and recommended intakes. time periods. There were no significant differences in any other reported nutrient intakes between the 2 groups.
DISCUSSION
Weight maintenance
Dietary studies investigating HP diets are usually conducted in the context of weight loss. Although randomized trials have indicated that carbohydrate-restricted diets are advantageous compared with higher-carbohydrate diets in achieving weight loss over 6 mo, longer trials have shown that the advantage is not sustained for 1 y (4, 11, 12) . In this study, significant weight loss after 3 mo of intensive dietary treatment was maintained for a year by following either an HC or an HP weight-maintenance diet. Others have found that diet composition does not influence weight regain when protein intake is kept constant and energy intake is ad libitum (13) .
Body composition
Some studies have found the loss of fat mass to be significantly greater in subjects following an HP diet as opposed to a highercarbohydrate diet (3, 14) , even with equivalent energy intakes and weight loss between the groups (15) . However, the findings are inconsistent. One study observed that subjects following a lowcarbohydrate diet lost significantly more lean tissue than did subjects following a low-fat, energy-restricted diet (16) . Clifton et al pooled data from 3 studies of 12-wk intakes of isocaloric HP (27-40% energy) and standard protein (15-20% of energy) intakes (17) . No difference was found between the diets for weight, fat mass, and lean mass loss.
Cardiovascular disease risk factors
Numerous studies have provided convincing evidence for the benefits of HP diets on cardiovascular disease risk factors (18) . Energy-restricted, HP diets have frequently been found to decrease triglycerides (4, 19, 20) and increase HDL cholesterol (4, 20) compared with energy-restricted, higher-carbohydrate diets. These improvements occurred even when there was no difference in weight loss between the HP and HC or low-carbohydrate treatment groups (15, 21) . When protein intake was constant but carbohydrate intake was reduced from 60% to 40%, the same reduced triglyceride and increased HDL pattern followed (22) .
It is plausible that the decreased carbohydrate-load characteristic of an HP diet can induce a reduction in blood pressure through a reduced insulin response. Insulin has been found to increase blood pressure (23, 24) ; subsequently, a reduction in insulin secretion may decrease blood pressure. Although there is evidence to suggest that HP diets induce a reduction in systolic and diastolic blood pressure in the short term (25, 26) , a systematic review of low-carbohydrate diets found no change is systolic blood pressure in participants following such diets (27) . In this study, all subjects experienced a reduction in blood pressure during phase 1 while following the VLED. However, during phase 2, only subjects in the HP diet group were able to sustain the reduction. The blood pressure of subjects in the HC group significantly increased during this time.
Diet
It has been suggested that, compared with high-GI carbohydrates, low-GI carbohydrates may delay the return of hunger and reduce subsequent food intake (28) . In the present study, both groups were prescribed low-GI carbohydrates, which possibly contributed to the overall satiety of both diets.
The increased satiety arising from an HP diet has been well established. In an ad libitum setting, this results in a spontaneous decrease in food intake (3, 14, 29) . However, in this study, the subjects in the HC and HP groups were prescribed isocaloric meal plans, and the data suggest that the subjects were compliant with macronutrient recommendations. Had the dietary prescriptions been more along the lines of ad libitum HP or HC diets, a spontaneous reduction in food intake may have been observed. Any potential satiating effect of protein on appetite may have been obscured in this study by the macronutrient and energy restrictions imposed on subjects through the meal plans provided.
Dietary compliance
A strength of this study was its free-living setting, in which no food was provided to subjects. However, this strength was also a weakness because it is difficult to measure dietary compliance. Reported energy intakes in both the HP and HC groups remained isocaloric, which supported the lack of difference in body weight. The difference in reported and calculated energy intakes for women suggested that the women had underestimated their food and thus energy intakes. Such a discrepancy was not found for the men. These findings are not unprecedented. A comparison of energy intakes determined by food diaries and energy expenditure measured by doubly labeled water found that middle-aged women taking part in a long-term diet-intervention trial underestimated their energy intake (30) . In the current study, neither group reported a significant increase in energy intake between months 9 and 15, despite a significant increase in weight experienced by the HP group (month 9, 1520 kcal; month 15, 1589 kcal; P = 0.620) and the HC group (month 9, 1639 kcal; month 15, 1678 calories; P = 0.864).
In this study, urinary nitrogen was not measured, but rather was calculated from urinary urea. Although this technique is not commonly used, its use in dietary studies such as this is not unprecedented (31, 32) , and it has been found to be a valuable approach to assessing nutritional therapy (33) .
According to the analysis of food diaries, the HP group reported excellent compliance with their macronutrient recommendations at months 9 and 15 ( Figure 2) . The protein intake of this group, calculated from urinary urea, supported the food diary reports. The HC group, however, struggled to consume the recommended amount of carbohydrate (55%) and to limit their protein intake to 15%. The most recent data on Australian food intake reports that the average intake of protein for Australian males and females is 17% of energy intake (34) . Our results suggest that subjects in the HC group were unable to sustain the prescribed lowered intake of protein. Although the HC group's mean protein intake during the study (21.7% of energy intake; 87.4 g/d indicated by the food diary or 110.2 g/d calculated) was significantly higher than the 15% prescribed, it was still significantly lower than the HP group's intake of 30.2% at both time points. (Table 7 and Figure 2 ). Although satiety was not formally measured in this study, it is possible that the HC group was not sufficiently satiated with the 15% protein recommendation. It is also tenable that the HP group may have been more truthful in recording their food intake. The authors are cognizant that the numbers of subjects completing food diaries and urine collections was disappointingly low, and, as such, are conservative in their declarations of dietary compliance.
Attrition
Dropout rates in year-long studies of persons following HP diets have ranged from 31% to 48% and from 37% to 50% for persons following low-fat diets (35) . The percentage of subjects who dropped out of the weight-maintenance dietary phase (phase 2) of our study was in keeping with these findings (41%). The percentage of subjects who began and completed both phases 1 and II of the dietary treatment was 47%. Although the number of subjects who withdrew from the study was high, the rate of attrition in both dietary treatment groups was equal, which suggests that the reason for withdrawal was not diet related.
To preserve the validity of comparisons between treatment groups, the ideal outcome would have been to follow all subjects who underwent randomization to completion of the study (36) . However, although this was not possible, we do not view this as a limitation of the study because the available data were handled by using the most appropriate statistical methods (CO, LOCF, and RTB). Furthermore, the sample size was large and the analyses using the RTB and LOCF methods supported the findings of those that completed the study, which thus strengthened the integrity of our results and provided reassurance that the results were not unduly biased by attrition.
Conclusions
The present study investigated whether dietary composition plays a role in improving weight maintenance after weight loss. Both the HP and HC groups sustained weight losses that were statistically and clinically significant. This indicated that freeliving overweight and obese people were able to comply with dietary recommendations and keep weight off over 12 mo. No statistically significant difference in maintained weight loss was observed between an HP and an HC diet. The effect of the increased protein intake on appetite may have been masked by the energy prescription imposed on subjects.
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